Lung Cancer :: GSK’s Hycamtin, topotecan capsules approved for treatment of small cell lung cancer
GlaxoSmithKline [NYSE: GSK] announced approval by the U.S. Food and Drug Administration (FDA) for oral Hycamtin ® (topotecan) capsules for the treatment of relapsed small cell lung cancer (SCLC).